SUBSCRIBE
SUBSCRIBE
News   Business

Alnylam Pharmaceuticals Reports Second Quarter 2008 Financial Results

August 6, 2008 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter of 2008, and company highlights.
Earnings
Alnylam Pharmaceuticals
MORE ON THIS TOPIC
top view squishy unicorn toy on a pastel pink background
Startups
AI-Focused Biotech Unicorns Face Chilly Market Where IPOs Aren’t Guaranteed
July 16, 2025
 · 
14 min read
 · 
Tristan Manalac
Female handshake. Flat design. Two business women in green and yellow clothes against the blue background of the metropolis shake hands
Leadership
5 Women Biotech Leaders Bagging Billions in M&A Dollars
July 16, 2025
 · 
8 min read
 · 
Tristan Manalac
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
 · 
6 min read
 · 
Lori Ellis
AbbVie's office in South San Francisco, California
Cancer
AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B
July 10, 2025
 · 
1 min read
 · 
Dan Samorodnitsky